We are live on
!
Find out more
SMA
Seven Mile Advisory Portfolio holdings
AUM
$139M
1-Year Est. Return
26.01%
This Fund
S&P 500
This Quarter
Est. Return
+16.05%
1 Year Est. Return
+26.01%
3 Year Est. Return
+102.71%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$166M
AUM Growth
+$16.5M
(+11%)
Cap. Flow
-$2.63M
Cap. Flow
% of AUM
-1.58%
Top 10 Holdings %
Top 10 Hldgs %
48.33%
Holding
188
New
13
Increased
46
Reduced
89
Closed
8
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$403K |
| 2 |
Dimensional Emerging Core Equity Market ETF
DFAE
|
+$349K |
| 3 |
Celestica
CLS
|
+$234K |
| 4 |
Pfizer
PFE
|
+$220K |
| 5 |
RTX Corp
RTX
|
+$201K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dimensional US Small Cap ETF
DFAS
|
+$749K |
| 2 |
Vanguard Short-Term Treasury ETF
VGSH
|
+$576K |
| 3 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$522K |
| 4 |
Apple
AAPL
|
+$424K |
| 5 |
Vanguard Total Bond Market
BND
|
+$297K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.65% |
| 2 | Financials | 9.45% |
| 3 | Communication Services | 8.58% |
| 4 | Consumer Discretionary | 6.72% |
| 5 | Healthcare | 5.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Gilead Sciences
GILD
$163B
| $343K | 0.21% |
3,098
+344
| +12% | +$36.6K |
|
102
Lam Research
LRCX
$372B
| $342K | 0.21% |
3,518
-556
| -14% | -$44.1K |
|
103
Manulife Financial
MFC
$74B
| $339K | 0.2% |
10,609
+136
| +1% | +$4.19K |
|
104
Copa Holdings
CPA
$5.8B
| $337K | 0.2% |
3,066
+653
| +27% | +$64.5K |
|
105
Stryker
SYK
$133B
| $336K | 0.2% |
850
-46
| -5% | -$17.2K |
|
106
Nu Holdings
NU
$70B
| $334K | 0.2% |
24,330
-221
| -0.9% | -$2.65K |
|
107
Merck
MRK
$321B
| $330K | 0.2% |
4,170
-1,155
| -22% | -$91.8K |
|
108
Citigroup
C
$222B
| $329K | 0.2% |
3,868
-99
| -2% | -$7.16K |
|
109
Boston Scientific
BSX
$68.4B
| $323K | 0.19% |
3,007
-85
| -3% | -$8.6K |
|
110
Schwab Fundamental International Large Company Index ETF
FNDF
$25.1B
| $320K | 0.19% |
8,000
| – | – |
|
111
VICI Properties
VICI
$29B
| $319K | 0.19% |
9,786
+877
| +10% | +$27.9K |
|
112
Vertex Pharmaceuticals
VRTX
$122B
| $317K | 0.19% |
712
+3
| +0.4% | +$1.38K |
|
113
Banco Santander
SAN
$202B
| $317K | 0.19% |
38,149
+972
| +3% | +$7.23K |
|
114
Adobe
ADBE
$98.5B
| $315K | 0.19% |
814
-278
| -25% | -$107K |
|
115
HSBC
HSBC
$367B
| $314K | 0.19% |
5,158
-298
| -5% | -$17K |
|
116
AstraZeneca
AZN
$266B
| $307K | 0.18% |
2,196
-84
| -4% | -$11.8K |
|
117
ARK Innovation ETF
ARKK
$5.77B
| $305K | 0.18% |
4,338
+22
| +0.5% | +$1.21K |
|
118
Cigna
CI
$76.1B
| $305K | 0.18% |
922
-46
| -5% | -$14.8K |
|
119
Vanguard Morningstar Growth ETF
VUG
$218B
| $295K | 0.18% |
4,038
| – | – |
|
120
iShares MSCI Japan ETF
EWJ
$22.1B
| $291K | 0.17% |
3,875
-42
| -1% | -$2.99K |
|
121
Banco Bilbao Vizcaya Argentaria
BBVA
$152B
| $287K | 0.17% |
18,670
-807
| -4% | -$11.6K |
|
122
Ares Capital
ARCC
$13.5B
| $285K | 0.17% |
13,000
| – | – |
|
123
Advanced Micro Devices
AMD
$791B
| $277K | 0.17% |
1,955
-258
| -12% | -$28.1K |
|
124
iShares US Treasury Bond ETF
GOVT
$43.7B
| $277K | 0.17% |
12,043
+202
| +2% | +$4.6K |
|
125
Danaher
DHR
$138B
| $276K | 0.17% |
1,397
-86
| -6% | -$16.7K |
|
Similar funds
CPW
MFF
PWM
AFW
PP
PAM
KCM
BCP
Seven Mile Advisory's Q2 2025 Portfolio in Review
As of Q2 2025, Seven Mile Advisory held 188 positions worth $166M, up 11% from $150M the previous quarter. Its ten largest holdings account for 48% of the portfolio.
Seven Mile Advisory's Q2 2025 filing shows 13 new, 46 increased, 89 reduced and 8 closed positions. Its largest new stake was Celestica: 2,205 shares worth $344K. The largest sale was Dimensional US Small Cap ETF, an estimated $749K.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 25% a quarter earlier, followed by Financials and Communication Services.
- Seven Mile Advisory's largest Q2 2025 buy was Celestica: 2,205 shares worth $344K.
- Seven Mile Advisory added most to Microsoft in Q2 2025, an estimated $403K increase.
- Seven Mile Advisory's biggest Q2 2025 reduction was Vanguard Short-Term Treasury ETF, cutting an estimated $576K.
- Seven Mile Advisory fully exited Dimensional US Small Cap ETF in Q2 2025, selling an estimated $749K.
- Seven Mile Advisory's ten largest holdings make up 48% of its $166M portfolio in Q2 2025.
- Seven Mile Advisory opened 13 new positions and closed 8 in Q2 2025.
- Seven Mile Advisory's portfolio value rose 11% quarter-over-quarter to $166M.
Based on Seven Mile Advisory's 13F filing for Q2 2025, filed 14 Aug 2025.